Lymph node biopsy after chemo for inflammatory breast cancer
Part of Cancer clinical trials.
This trial is testing if a less invasive sentinel lymph node biopsy can replace more extensive lymph node removal in women with inflammatory breast cancer who have had chemotherapy and whose nodes appear cancer-free. This could help avoid unnecessary side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 or older with inflammatory breast cancer (stage IIIB).
- You must have completed chemotherapy and your lymph nodes now show no signs of cancer on exam and scans.
- You do not have cancer that has spread to other parts of the body or to the opposite armpit.
- You have not had breast cancer in the same breast before.
- You are not pregnant.
- You are willing to have all armpit lymph nodes removed if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a targeted surgical approach to remove only the suspicious lymph nodes under the arm for people with early-stage, hormone receptor positive, HER2 negative breast cancer. The goal is to see if this less extensive surgery is safe and effective when there is limited lymph node involvement.
This study tests whether a less invasive lymph node biopsy is effective for women with inflammatory breast cancer who have finished chemotherapy and are having surgery. It could help doctors know if the cancer has spread to lymph nodes without removing all of them.
This trial checks whether a less invasive sentinel lymph node biopsy (removing just a few nodes) can safely replace full lymph node removal for people whose breast cancer and underarm lymph nodes responded well to chemotherapy. It is for patients who initially had 1 to 3 involved nodes and now appear cancer-free in the armpit.
This trial tests a less extensive armpit surgery after chemotherapy for breast cancer that had spread to lymph nodes. The goal is to see if removing only the sentinel nodes (guided by blue dye) is safe and effective when nodes appear clear after treatment.
This trial studies how doctors should operate on lymph nodes after you finish chemotherapy given before surgery. It may help improve treatment planning for people whose breast cancer has spread to nearby lymph nodes, but not to distant organs.
This study tests whether some women with breast cancer that has spread to lymph nodes can safely avoid a more extensive lymph node surgery after chemotherapy. If the cancer responds well to chemo, a less invasive procedure may be used.
Hear when a new Invasive Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.